Lv611
1745 积分 2020-08-26 加入
Global variations in lung cancer incidence by histological subtype in 2020: a population-based study
8个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
8个月前
已完结
Cancer incidence and mortality in China, 2022
8个月前
已完结
Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study
9个月前
已完结
A Phase 2 Study of Docetaxel, Ramucirumab, and Pembrolizumab for Patients With Metastatic or Recurrent Non–Small-Cell Lung Cancer (NSCLC) who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade
9个月前
已完结
Targeting programmed cell death protein 1 (PD-1) for treatment of non-small-cell lung carcinoma (NSCLC); the recent advances
9个月前
已完结
Impact of treatment timing and sequence of immune checkpoint inhibitors and anti-angiogenic agents for advanced non-small cell lung cancer: A systematic review and meta-analysis
9个月前
已完结
Anti-angiogenesis revisited: reshaping the treatment landscape of advanced non-small cell lung cancer
9个月前
已完结
Combination of radiotherapy and Anlotinib enhances benefit from immunotherapy to liver metastasis and abscopal tumor from lung cancer
9个月前
已完结
皖公网安备34019202002308
